Global Biochips Markets 2016-2024: Strategic Business Report 2018 - Biochips with CMOS Technology for Aiding Cheaper Cancer and Other Diagnoses - ResearchAndMarkets.com

DUBLIN--()--The "Biochips - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets in US$ Million by the following Segments:

  • DNA Biochips
  • Protein Biochips
  • Lab-on-a-Chip
  • Others

The report further analyzes the market by the following Applications:

  • Research
  • Diagnostics
  • Others

The report profiles 72 companies including many key and niche players such as:

  • Agilent Technologies, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Cepheid Inc. (US)
  • Fluidigm Corporation (US)
  • GE Healthcare (US)
  • Hoffman-La-Roche Ltd. (Switzerland)
  • Illumina, Inc. (US)
  • Ocimum Biosolutions Ltd. (India)
  • PerkinElmer, Inc. (US)
  • Takara Bio Inc. (Japan)
  • Takara Bio USA, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)

Key Topics Covered

1. Introduction, Methodology & Product Definitions

2. Industry Overview

3. Growth Drivers, Market Trends, and Challenges

  • Biochips Aid in Alleviating Issues Associated with Immunological Studies
  • Challenges for Widespread Adoption
  • Biochips with CMOS Technology for Aiding Cheaper Cancer and Other Diagnoses
  • Development of Protein Microarrays for the Field of Diagnostics - Key Challenges
  • Reproducibility - the Key Issue
  • Ease of Use
  • Cost
  • Implantable Biochip: The Next Thing in the Wearables Market
  • Going Mainstream
  • Drug Discovery Applications to Drive Market
  • Proteomics and Genomics Drive Demand for Biochips
  • Growing Preference for DNA/Protein Biochips in Personalized Medicine
  • Application of Biochips in Drug Discovery - A Strong Growth Driver
  • Cancer: An Important Driver for the Biochips Market
  • Increasing Prevalence of Lifestyle Diseases Boost Diagnostic Microarray Market
  • Diabetes - A Statistical Overview
  • Government Efforts to Promote Biochip Technology
  • Integrating Tools with Diagnostic Capabilities with Smartphones - A Futuristic Trend
  • Microfluidic and Lab-on-a-chip Devices for Pharmacogenomics
  • Lab-on-a-Chip System for Better Pulmonary Disease Outcome
  • Industry Challenges
  • Standardization: A Key Challenge
  • High Costs Restrain Growth
  • Precise Protein Detection: A Challenge

4. Innovations in the Biochips Industry

5. Product Overview

6. Biochip and Microarray Construction

7. Applications of Biochips

8. Competitive Landscape

9. Global Market Perspective

10. Company Profiles

Total Companies Profiled: 72 (including Divisions/Subsidiaries - 78)

  • The United States (39)
  • Canada (2)
  • Japan (6)
  • Europe (21)
    • France (2)
    • Germany (7)
    • The United Kingdom (3)
    • Spain (1)
    • Rest of Europe (8)
  • Asia-Pacific (Excluding Japan) (10)

For more information about this report visit https://www.researchandmarkets.com/research/br3qvk/global_biochips?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology